BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27764844)

  • 1. In the Wnt-er of life: Wnt signalling in melanoma and ageing.
    Kaur A; Webster MR; Weeraratna AT
    Br J Cancer; 2016 Nov; 115(11):1273-1279. PubMed ID: 27764844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Wnts of change: How Wnts regulate phenotype switching in melanoma.
    Webster MR; Kugel CH; Weeraratna AT
    Biochim Biophys Acta; 2015 Dec; 1856(2):244-51. PubMed ID: 26546268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Wnt-er wonderland--the complexity of Wnt signaling in melanoma.
    Weeraratna AT
    Cancer Metastasis Rev; 2005 Jun; 24(2):237-50. PubMed ID: 15986134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt-signalling and the metabolic syndrome.
    Schinner S
    Horm Metab Res; 2009 Feb; 41(2):159-63. PubMed ID: 19214925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sailing with the Wnt: charting the Wnt processing and secretion route.
    Lorenowicz MJ; Korswagen HC
    Exp Cell Res; 2009 Oct; 315(16):2683-9. PubMed ID: 19559695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt/β-catenin signalling: from plasma membrane to nucleus.
    Kim W; Kim M; Jho EH
    Biochem J; 2013 Feb; 450(1):9-21. PubMed ID: 23343194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WNT5A expression increases during melanoma progression and correlates with outcome.
    Da Forno PD; Pringle JH; Hutchinson P; Osborn J; Huang Q; Potter L; Hancox RA; Fletcher A; Saldanha GS
    Clin Cancer Res; 2008 Sep; 14(18):5825-32. PubMed ID: 18794093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARgamma agonists attenuate proliferation and modulate Wnt/beta-catenin signalling in melanoma cells.
    Smith AG; Beaumont KA; Smit DJ; Thurber AE; Cook AL; Boyle GM; Parsons PG; Sturm RA; Muscat GE
    Int J Biochem Cell Biol; 2009 Apr; 41(4):844-52. PubMed ID: 18822385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Specific targeting of Wnt/β-catenin signaling in human melanoma cells by a dietary triterpene lupeol.
    Biechele TL; Chien AJ
    Carcinogenesis; 2011 Jan; 32(1):120; author reply 121. PubMed ID: 20980347
    [No Abstract]   [Full Text] [Related]  

  • 10. Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature.
    Hoek KS; Schlegel NC; Brafford P; Sucker A; Ugurel S; Kumar R; Weber BL; Nathanson KL; Phillips DJ; Herlyn M; Schadendorf D; Dummer R
    Pigment Cell Res; 2006 Aug; 19(4):290-302. PubMed ID: 16827748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Wnt signalling the final common pathway leading to bone formation?
    Milat F; Ng KW
    Mol Cell Endocrinol; 2009 Oct; 310(1-2):52-62. PubMed ID: 19524639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt5a/Ca (2+) /calcineurin/nuclear factor of activated T signaling pathway as a potential marker of pediatric melanoma.
    Yang Y; Qian Q
    J Cancer Res Ther; 2014 Nov; 10 Suppl():C83-8. PubMed ID: 25450290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt/β-catenin signaling is stimulated by α-melanocyte-stimulating hormone in melanoma and melanocyte cells: implication in cell differentiation.
    Bellei B; Pitisci A; Catricalà C; Larue L; Picardo M
    Pigment Cell Melanoma Res; 2011 Apr; 24(2):309-25. PubMed ID: 21040502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer.
    Zardawi SJ; O'Toole SA; Sutherland RL; Musgrove EA
    Histol Histopathol; 2009 Mar; 24(3):385-98. PubMed ID: 19130408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Wnt signalling by receptor-mediated endocytosis.
    Kikuchi A; Yamamoto H
    J Biochem; 2007 Apr; 141(4):443-51. PubMed ID: 17317692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential.
    Murakami T; Toda S; Fujimoto M; Ohtsuki M; Byers HR; Etoh T; Nakagawa H
    Biochem Biophys Res Commun; 2001 Oct; 288(1):8-15. PubMed ID: 11594745
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Baarsma HA; Königshoff M
    Thorax; 2017 Aug; 72(8):746-759. PubMed ID: 28416592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Wnt5a and its downstream effector beta-catenin in uveal melanoma.
    Zuidervaart W; Pavey S; van Nieuwpoort FA; Packer L; Out C; Maat W; Jager MJ; Gruis NA; Hayward NK
    Melanoma Res; 2007 Dec; 17(6):380-6. PubMed ID: 17992121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt signalling in lung development and diseases.
    Pongracz JE; Stockley RA
    Respir Res; 2006 Jan; 7(1):15. PubMed ID: 16438732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secrets to developing Wnt-age melanoma revealed.
    Larue L; Delmas V
    Pigment Cell Melanoma Res; 2009 Oct; 22(5):520-1. PubMed ID: 19558582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.